[Tree] Genmab's acquisition of ProfoundBio, MediLink Therapeutics' expanded partnership with BioNTech, Aptamer Group signs contracts with top pharmaceutical company

Version 0.1 (2024-06-24 07:28:34.756000)

updates: Inclusion of Aptamer Group signing contracts with top pharmaceutical company

  • ➔
Version 0.09 (2024-05-27 01:36:43.742000)

updates: Genmab acquires ProfoundBio; MediLink expands partnership with BioNTech

  • ➔
  • ➔
Version 0.08 (2024-04-04 13:23:17.425000)

updates: Genmab's acquisition of ProfoundBio to strengthen ADC portfolio

  • ➔
Version 0.07 (2024-03-22 21:25:37.983000)

updates: Merger between Axonics and Boston Scientific approved by shareholders

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-03-19 22:24:48.417000)

updates: AEON Biopharma aligns with FDA on Phase 3 migraine trials

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-03-19 22:21:41.831000)

updates: Inclusion of information about AEON Biopharma's private placement and funding for the late-stage clinical development of ABP-450

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-02-08 10:55:14.196000)

updates: Syncona quarterly update on net assets and portfolio value; Autolus achieves milestone with FDA filing; Operational and governance changes at Syncona

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2023-12-14 01:26:07.138000)

updates: Integration of information about the AIBN's research and projects

  • ➔
  • ➔
  • ➔
Version 0.02 (2023-11-20 16:55:13.814000)

updates: Integration of the SYNBEE Day 2024 announcement

  • ➔
  • ➔
Version 0.01 (2023-11-13 09:45:40.203000)

updates: Restructured and revised story

  • ➔
Version 0.0 (2023-11-13 09:38:55.870000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔